The researchers are characterising the neurobehavioural profile of individuals with Friedreich ataxia during an ocular motor task which specifically invokes response inhibition and task switching. The impact of eye movement abnormalities in Friedreich ataxia The National Ataxia Foundation (USA) funds this study. The group is using neuroimaging techniques to explore the role of cerebellar pathology in the hearing impairment associated with Friedreich ataxia and spinocerebellar ataxia. The effect of cerebellar abnormality on hearing in individuals with Friedreich ataxia and spinocerebellar ataxia The National Health and Medical Research Council (NHMRC) funds this study. The team is undertaking a four-year longitudinal study to investigate the clinical, neurocognitive, behavioural (motor/cognitive), and neurobiological profile of Friedreich ataxia. A functional magnetic resonance imaging (fMRI) study addressing cognitive function in individuals with Friedreich Ataxia FARA (USA) has partially funded this study. These are soon to be published and is revised every two years. The researchers have led an international effort to produce clinical management guidelines for Friedreich ataxia. Development of Clinical Management Guidelines for Friedreich ataxia The group is also the Australasian site for a major international Friedreich ataxia database, the Collaborative Clinical Research Network in Friedreich's Ataxia (USA). The team studies people with Friedreich ataxia annually to understand the natural history of the disorder on the various body systems affected and perceived quality of life. Study of the impact of Friedreich ataxia on the nervous system, heart and quality of life The group is now working toward a placebo-controlled study. In the study, people treated with high dose resveratrol had a reduction in oxidative stress markers and improvement in several clinical measures. The team has shown that resveratrol increases frataxin levels in vitro and in vivo. Friedreich ataxia clinical studies Study of resveratrol as a treatment for Friedreich ataxia Please support the Australian Friedreich Ataxia Stem Cell and Gene Therapy Consortium. The Consortium’s vision is to facilitate and undertake Friedreich ataxia cell and gene therapy clinical trials leading to successful outcomes for patients as soon as possible. The Consortium is a strategic alliance of pre-eminent experts in Friedreich Ataxia, Stem Cells, Gene Therapy, Policy, Advocacy and Regulation. CRDO Core Workshops: Practical skills in researchĪustralian Friedreich Ataxia Stem Cell and Gene Therapy Consortium.CRDO Workshops: Clinical research, skills & practice workshops.Observational studies: Modern concepts & analytic methods.CEBU research methods and software training.Stronger Futures Centre of Research Excellence.Early career researchers (ECR) launching pad.NHMRC Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific.Centre of Research Excellence in Neuromuscular Disorders.Centre of Research Excellence in Global Adolescent Health.Centre of Research Excellence in Child Language.Centre of Research Excellence in Childhood Adversity.Centre of Research Excellence in Newborn Medicine.Centre of Research Excellence in Speech and Language.Paediatric Emergency Medicine Centre of Research Excellence.Centre for Ethics of Paediatric Genomics.Adolescent Health and Wellbeing Flagship.COVID-19 Infection, immunity and transmission in children.Our COVID-19 children's research program.Clinical Epidemiology & Biostatistics CEBU.Vaccine and immunisation research group (VIRGO).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |